Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A
- 7 June 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 319 (4) , 1210-1215
- https://doi.org/10.1016/j.bbrc.2004.05.104
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy.Cardiovascular Research, 2003
- Construction of Transgenic Mice with Tissue-Specific Acceleration of Mitochondrial DNA MutagenesisGenomics, 2000
- Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transitionBiochemical Journal, 1998
- Regulation of the Permeability Transition Pore in Skeletal Muscle MitochondriaJournal of Biological Chemistry, 1998
- The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related ProteinsThe Journal of Experimental Medicine, 1998
- Induction of the Mitochondrial Permeability Transition Causes Release of the Apoptogenic Factor Cytochrome cFree Radical Biology & Medicine, 1998
- Redox Regulation of the Mitochondrial Permeability Transition PoreBioscience Reports, 1997
- Mitochondria Are Excitable Organelles Capable of Generating and Conveying Electrical and Calcium SignalsCell, 1997
- Protection by Cyclosporin A of Ischemia/Reperfusion-Induced Damage in Isolated Rat HeartsJournal of Molecular and Cellular Cardiology, 1993
- The Ca2+-induced membrane transition in mitochondriaArchives of Biochemistry and Biophysics, 1979